Correlation Between Stoke Therapeutics and Taysha Gene
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Taysha Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Taysha Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Taysha Gene Therapies, you can compare the effects of market volatilities on Stoke Therapeutics and Taysha Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Taysha Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Taysha Gene.
Diversification Opportunities for Stoke Therapeutics and Taysha Gene
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Stoke and Taysha is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Taysha Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taysha Gene Therapies and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Taysha Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taysha Gene Therapies has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Taysha Gene go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Taysha Gene
Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the Taysha Gene. But the stock apears to be less risky and, when comparing its historical volatility, Stoke Therapeutics is 3.47 times less risky than Taysha Gene. The stock trades about -0.09 of its potential returns per unit of risk. The Taysha Gene Therapies is currently generating about 0.38 of returns per unit of risk over similar time horizon. If you would invest 134.00 in Taysha Gene Therapies on September 4, 2024 and sell it today you would earn a total of 174.00 from holding Taysha Gene Therapies or generate 129.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Taysha Gene Therapies
Performance |
| Timeline |
| Stoke Therapeutics |
| Taysha Gene Therapies |
Stoke Therapeutics and Taysha Gene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Taysha Gene
The main advantage of trading using opposite Stoke Therapeutics and Taysha Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Taysha Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taysha Gene will offset losses from the drop in Taysha Gene's long position.| Stoke Therapeutics vs. Candel Therapeutics | Stoke Therapeutics vs. Cingulate Warrants | Stoke Therapeutics vs. Unicycive Therapeutics | Stoke Therapeutics vs. Cardio Diagnostics Holdings |
| Taysha Gene vs. Biomea Fusion | Taysha Gene vs. Stoke Therapeutics | Taysha Gene vs. Akero Therapeutics | Taysha Gene vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |